FDA approves ARS’ neffy 1mg for paediatric anaphylaxis

FDA has granted approval for ARS Pharmaceuticals’ neffy 1mg for treating anaphylaxis in paediatric patients.

Leave a Reply

Your email address will not be published. Required fields are marked *